Modern medicine has made remarkable advances in treating metabolic disease. We have more effective medications, better clinical guidelines, and a deeper understanding of the interplay between obesity, diabetes, cardiovascular disease, and mental health.
Digital health has expanded what’s possible, providing new tools for effective monitoring, engagement, and behavior change. And yet, the industry still relies too heavily on episodic data and fragmented solutions to guide care for inherently dynamic and interconnected conditions.
The measurement problem hiding in plain sight
Part of the problem lies in how the industry measures a comprehensive problem like metabolic disease. BMI has long served as a proxy for obesity, while A1C is used to assess glycemic control. Blood pressure and lipid levels are tracked separately. Each metric offers a narrow view of one aspect of health, and none capture the full picture.
Two patients with similar values on any one of these measures can have vastly different underlying risks. While one patient may be metabolically stable and improving, another may be on a trajectory toward greater instability and higher-cost intervention.
Without a comprehensive view, providers are left managing symptoms of metabolic dysfunction rather than the system itself.
Digital health has scaled fragmentation
Digital health should solve this; however, in many cases, it has reinforced the problem.
We have built point solutions around individual conditions and metrics — one for weight, another for diabetes, another for hypertension — each generating its own data, interventions, and definition of success.
However, metabolic disease does not operate in silos. It is a syndrome driven by overlapping physiological, behavioral, and environmental factors.
When care is delivered through disconnected programs, critical context is lost as signals are not integrated, risk is not fully understood, and care is not calibrated to the whole person. More tools have not led to better control. In reality, they have made the system harder to navigate and manage.
From isolated metrics to metabolic control
Our measurement framework must be as dynamic and multidimensional as metabolic health itself.
There is a need for a more comprehensive way to assess metabolic control — one that integrates clinical indicators, behavioral patterns, and overall complexity into a single, longitudinal view of patient health.
By incorporating factors such as glycemic trends, weight trajectory, blood pressure, lipid levels, comorbidities, medication burden, and behavioral consistency, clinicians can move beyond static thresholds to understand where a patient truly sits on the spectrum of metabolic stability.
This kind of model does more than describe current health, it creates a forward-looking line of sight, helping identify which patients are stable, which are showing early signs of instability, and which require more intensive intervention. In other words, it enables us to get ahead of the problem, not just react to it.
The role of continuous insight
A comprehensive scoring model is only as powerful as the data that informs it.This is where digital health can, and should, play a different role.
Continuous biometric signals, such as sleep patterns, heart rate variability, activity, and recovery, provide important context for understanding how an individual’s health evolves over time.
Rather than operating as standalone engagement tools, monitoring technologies must become part of a broader clinical framework, enhancing clinical visibility, improving decision-making, and enabling earlier, more targeted interventions.
This is the shift from digital health as a collection of tools to digital health as a clinical infrastructure.
Aligning care to what actually matters
With a complete understanding of metabolic control, care delivery can finally align with patient needs. Lower acuity individuals can be supported through lifestyle and behavioral interventions, with the goal of preventing disease progression. Those with greater complexity and higher acuity can receive more intensive, physician-led care, including medication management and coordinated treatment across conditions.
Conditions are not determined by a single diagnosis or threshold, but by a holistic assessment of where the patient is and where they are headed, reducing both under-treatment and over-medicalization, while improving the likelihood of durable outcomes.
The system is overdue for a reset
Metabolic disease is one of the most significant drivers of healthcare cost and complexity. It is also one of the clearest examples of where our measurement frameworks are due for an update.
The future of metabolic care will not be defined by a single metric or a proliferation of point solutions. It will be defined by our ability to measure metabolic health comprehensively, understand it continuously, and act on it proactively.
Photo:Yutthana Gaetgeaw, Getty Images
Richard Frank, MD, MHSA, Chief Medical Officer, Vida Health is an experienced physician executive with demonstrated success in product development and strategy, managing high-risk Medicare and Medicaid populations, developing new business for established and VC-backed companies, engaging providers in value-based contracts, controlling healthcare utilization, and implementing clinical programs within not-for-profit and publicly traded companies.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
